In The News Posted December 31, 2019 Share Posted December 31, 2019 NEW YORK, Dec. 31, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Adamas Pharmaceuticals, Inc. between August 8, 2017 and September 30, 2019, inclusive (the "Class Period") of the important February 10, 2020 lead plaintiff... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.